UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

The New England journal of medicine, 2012-03, Vol.366 (12), p.1079-1089

2012

Volltextzugriff (PDF)

Chiral phosphoric acid and its applications of asymmetric catalytic hydrogenation

E3S Web of Conferences, 2021, Vol.290, p.1008

2021

Volltextzugriff (PDF)

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

Journal of clinical oncology, 2016-03, Vol.34 (9), p.927-935

2016

Volltextzugriff (PDF)

Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905

Journal of clinical oncology, 2014-04, Vol.32 (12), p.1242-1248

2014

Volltextzugriff (PDF)

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

Journal of clinical oncology, 2013-09, Vol.31 (25), p.3083-3090

2013

Volltextzugriff (PDF)

Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation

Journal of clinical oncology, 2013-09, Vol.31 (25), p.3158-3161

2013

Volltextzugriff (PDF)

Anthracycline Dose Intensification in Acute Myeloid Leukemia

The New England journal of medicine, 2009-09, Vol.361 (13), p.1249-1259

2009

Volltextzugriff (PDF)

Catalytic Asymmetric Transfer Hydrogenation of trans-Chalcone Derivatives Using BINOL-derived Boro-phosphates

Organic letters, 2020-08, Vol.22 (15), p.5953-5957

2020

Volltextzugriff (PDF)

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups

Blood, 2016-03, Vol.127 (12), p.1551-1558

2016

Volltextzugriff (PDF)

Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia

Blood, 2013-06, Vol.121 (24), p.4917-4924

2013

Volltextzugriff (PDF)

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)

Blood, 2009-09, Vol.114 (12), p.2393-2400

2009

Volltextzugriff (PDF)

Effect of Complete Remission and Responses Less Than Complete Remission on Survival in Acute Myeloid Leukemia: A Combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1766-1771

2010

Volltextzugriff (PDF)

Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models

Nature neuroscience, 2006-02, Vol.9 (2), p.251-259

2006

Volltextzugriff (PDF)

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

Breast cancer research and treatment, 2021-02, Vol.185 (3), p.697-707

2021

Volltextzugriff (PDF)

The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys

Neuropsychopharmacology (New York, N.Y.), 2005-09, Vol.30 (9), p.1649-1661

2005

Volltextzugriff (PDF)

Lamina-Specific Reductions in Dendritic Spine Density in the Prefrontal Cortex of Subjects With Schizophrenia

The American journal of psychiatry, 2005-06, Vol.162 (6), p.1200-1202

2005

Volltextzugriff (PDF)

CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900

Blood, 2012-09, Vol.120 (11), p.2297-2306

2012

Volltextzugriff (PDF)

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial

Breast (Edinburgh), 2020-10, Vol.53, p.1-7

2020

Volltextzugriff (PDF)

Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia

The Journal of neuroscience, 2005-01, Vol.25 (2), p.372-383

2005

Volltextzugriff (PDF)

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial

BMJ open, 2022-01, Vol.12 (1), p.e057663

2022

Volltextzugriff (PDF)

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS9077-TPS9077

2020

Volltextzugriff (PDF)

Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine‐treated patients with myelodysplastic syndromes

British journal of haematology, 2014-08, Vol.166 (3), p.352-359

2014

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(74)
Humans
(59)
Female
(39)
Middle Aged
(39)
Oncology
(38)
Male
(30)
Aged
(26)
Adult
(25)
Prognosis
(20)
Hematology
(19)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Chemotherapy
(15)
Leukemia, Myeloid, Acute - Drug Therapy
(15)
Physical Sciences
(15)
Adolescent
(14)
Aged, 80 And Over
(13)
Leukemia, Myeloid, Acute - Genetics
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(42)
Journal Of Clinical Oncology
(19)
Breast Cancer Research And Treatment
(4)
British Journal Of Haematology
(4)
Biological Psychiatry
(3)
Breast
(3)
Forests
(3)
Leukemia
(3)
Leukemia Research
(3)
Plos One
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

Chiral phosphoric acid and its applications of asymmetric catalytic hydrogenation

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

Anthracycline Dose Intensification in Acute Myeloid Leukemia

Catalytic Asymmetric Transfer Hydrogenation of trans-Chalcone Derivatives Using BINOL-derived Boro-phosphates

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups

Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)

Effect of Complete Remission and Responses Less Than Complete Remission on Survival in Acute Myeloid Leukemia: A Combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys

Lamina-Specific Reductions in Dendritic Spine Density in the Prefrontal Cortex of Subjects With Schizophrenia

CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial

Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC

Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine‐treated patients with myelodysplastic syndromes

Suchergebnisse filtern